Discovery of a first-in-class reversible DNMT1-selective inhibitor

被引：0
|
作者：
Pappalardi, Melissa B. [1 ]
机构：
[1] GlaxoSmithKline, Collegeville, PA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3265
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia
    Pappalardi, Melissa B.
    Keenan, Kathryn
    Cockerill, Mark
    Kellner, Wendy A.
    Stowell, Alexandra
    Sherk, Christian
    Wong, Kristen
    Pathuri, Sarath
    Briand, Jacques
    Steidel, Michael
    Chapman, Philip
    Groy, Arthur
    Wiseman, Ashley K.
    McHugh, Charles F.
    Campobasso, Nino
    Graves, Alan P.
    Fairweather, Emma
    Werner, Thilo
    Raoof, Ali
    Butlin, Roger J.
    Rueda, Lourdes
    Horton, John R.
    Fosbenner, David T.
    Zhang, Cunyu
    Handler, Jessica L.
    Muliaditan, Morris
    Mebrahtu, Makda
    Jaworski, Jon-Paul
    McNulty, Dean E.
    Burt, Charlotte
    Eberl, H. Christian
    Taylor, Amy N.
    Ho, Thau
    Merrihew, Susan
    Foley, Shawn W.
    Rutkowska, Anna
    Li, Mei
    Romeril, Stuart P.
    Goldberg, Kristin
    Zhang, Xing
    Kershaw, Christopher S.
    Bantscheff, Marcus
    Jurewicz, Anthony J.
    Minthorn, Elisabeth
    Grandi, Paola
    Patel, Mehul
    Benowitz, Andrew B.
    Mohammad, Helai P.
    Gilmartin, Aidan G.
    Prinjha, Rab K.
    NATURE CANCER, 2021, 2 (10) : 1002 - +
  • [2] Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia
    Melissa B. Pappalardi
    Kathryn Keenan
    Mark Cockerill
    Wendy A. Kellner
    Alexandra Stowell
    Christian Sherk
    Kristen Wong
    Sarath Pathuri
    Jacques Briand
    Michael Steidel
    Philip Chapman
    Arthur Groy
    Ashley K. Wiseman
    Charles F. McHugh
    Nino Campobasso
    Alan P. Graves
    Emma Fairweather
    Thilo Werner
    Ali Raoof
    Roger J. Butlin
    Lourdes Rueda
    John R. Horton
    David T. Fosbenner
    Cunyu Zhang
    Jessica L. Handler
    Morris Muliaditan
    Makda Mebrahtu
    Jon-Paul Jaworski
    Dean E. McNulty
    Charlotte Burt
    H. Christian Eberl
    Amy N. Taylor
    Thau Ho
    Susan Merrihew
    Shawn W. Foley
    Anna Rutkowska
    Mei Li
    Stuart P. Romeril
    Kristin Goldberg
    Xing Zhang
    Christopher S. Kershaw
    Marcus Bantscheff
    Anthony J. Jurewicz
    Elisabeth Minthorn
    Paola Grandi
    Mehul Patel
    Andrew B. Benowitz
    Helai P. Mohammad
    Aidan G. Gilmartin
    Rab K. Prinjha
    Nature Cancer, 2021, 2 : 1002 - 1017
  • [3] Discovery of a first-in-class ERK 1,2 inhibitor
    Samatar, Ahmed A.
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [4] Discovery of the first-in-class SHP1 covalent inhibitor for cancer immunotherapy
    Qu, Zihan
    Meke, Frederick Nguele
    Zhang, Zheng
    Bai, Yunpeng
    Krabill, Aaron D.
    Muli, Christine S.
    Jassim, Brenson A.
    Dong, Jiajun
    Li, Jinyue
    Yuyen, Nguyen
    Tao, Andy W.
    Trader, Darci T.
    Zhang, Zhong-Yin
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Discovery of a first-in-class allosteric inhibitor of the small GTPase Rac1
    Silverman, Robert
    Cooper, Alan
    Kar, Ronodip
    Raman, Mayuri V.
    Ravirala, Ramu
    Shah, Mubarak Hasan
    Mahankali, Sandeep
    Goka, Erik T.
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Discovery of a first-in-class orally available HBV cccDNA inhibitor
    Wang, Li
    Zhu, Qihui
    Zhang, Jitao David
    Zhang, Yaling
    Ni, Xiaoju
    Xiang, Kunlun
    Jiang, Jiaxi
    Li, Baocun
    Yu, Youjun
    Hu, Hui
    Zhang, Meifang
    Wu, Waikwong
    Zeng, Jing
    Yan, Zhipeng
    Dai, Jieyu
    Sun, Kai
    Zhang, Xin
    Chen, Dongdong
    Feng, Song
    Sach-Peltason, Lisa
    Young, John A. T.
    Gao, Lu
    JOURNAL OF HEPATOLOGY, 2023, 78 (04) : 742 - 753
  • [7] Discovery and Characterization of Selective, First-in-Class Inhibitors of Citron Kinase
    Maw, Joshua J.
    Coker, Jesse A.
    Arya, Tarun
    Goins, Christopher M.
    Sonawane, Dhiraj
    Han, Sang Hoon
    Rees, Matthew G.
    Ronan, Melissa M.
    Roth, Jennifer A.
    Wang, Nancy S.
    Heemers, Hannelore V.
    Macdonald, Jonathan D.
    Stauffer, Shaun R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (04) : 2631 - 2666
  • [8] Discovery of a first-in-class EZH2 selective degrader
    Ma, Anqi
    Stratikopoulos, Elias
    Park, Kwang-Su
    Wei, Jieli
    Martin, Tiphaine C.
    Yang, Xiaobao
    Schwarz, Megan
    Leshchenko, Violetta
    Rialdi, Alexander
    Dale, Brandon
    Lagana, Alessandro
    Guccione, Ernesto
    Parekh, Samir
    Parsons, Ramon
    Jin, Jian
    NATURE CHEMICAL BIOLOGY, 2020, 16 (02) : 214 - +
  • [9] Discovery of a first-in-class EZH2 selective degrader
    Anqi Ma
    Elias Stratikopoulos
    Kwang-Su Park
    Jieli Wei
    Tiphaine C. Martin
    Xiaobao Yang
    Megan Schwarz
    Violetta Leshchenko
    Alexander Rialdi
    Brandon Dale
    Alessandro Lagana
    Ernesto Guccione
    Samir Parekh
    Ramon Parsons
    Jian Jin
    Nature Chemical Biology, 2020, 16 : 214 - 222
  • [10] Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer
    Kwon, Whi-An
    Seo, Ho Kyung
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (03) : 1319 - 1321
12345